Mitigating the risks of post-acute sequelae of SARS-CoV-2 infection (PASC) with intranasal chlorpheniramine: perspectives from the ACCROS studies
This interesting study shows that use of intranasal antihistamine chlorpheniramine may prevent COVID-19 progression to Long COVID when used during acute infection.